121 related articles for article (PubMed ID: 12743423)
41. Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas.
Bukholm IR; Bukholm G; Nesland JM
APMIS; 2002 Mar; 110(3):214-20. PubMed ID: 12076274
[TBL] [Abstract][Full Text] [Related]
42. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
[TBL] [Abstract][Full Text] [Related]
43. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients.
Kapranos N; Karaiosifidi H; Valavanis C; Kouri E; Vasilaros S
Anticancer Res; 1997; 17(4A):2499-505. PubMed ID: 9252670
[TBL] [Abstract][Full Text] [Related]
45. Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome?
Feinmesser M; Halpern M; Fenig E; Tsabari C; Hodak E; Sulkes J; Brenner B; Okon E
Hum Pathol; 1999 Nov; 30(11):1367-72. PubMed ID: 10571519
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.
Sturm I; Köhne CH; Wolff G; Petrowsky H; Hillebrand T; Hauptmann S; Lorenz M; Dörken B; Daniel PT
J Clin Oncol; 1999 May; 17(5):1364-74. PubMed ID: 10334520
[TBL] [Abstract][Full Text] [Related]
47. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
Farid P; Gomb SZ; Péter I; Szende B
Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical analysis of p53 expression in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty KK
Anticancer Res; 1998; 18(1A):65-70. PubMed ID: 9568057
[TBL] [Abstract][Full Text] [Related]
51. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors.
Zapata JM; Krajewska M; Krajewski S; Huang RP; Takayama S; Wang HG; Adamson E; Reed JC
Breast Cancer Res Treat; 1998 Jan; 47(2):129-40. PubMed ID: 9497101
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of expression and correlation between P53, BCL-2 and BAX proteins in ovarian neoplasms].
Bar JK; Sobańska E; Popiela A; Goluda M
Ginekol Pol; 2002 Feb; 73(2):102-9. PubMed ID: 12001767
[TBL] [Abstract][Full Text] [Related]
53. Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas.
Sierra A; Castellsagué X; Coll T; Mañas S; Escobedo A; Moreno A; Fabra A
Int J Cancer; 1998 Apr; 79(2):103-10. PubMed ID: 9583721
[TBL] [Abstract][Full Text] [Related]
54. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
[TBL] [Abstract][Full Text] [Related]
55. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A
Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455
[TBL] [Abstract][Full Text] [Related]
56. Reduced mRNA and protein expression of BCL-2 versus decreased mRNA and increased protein expression of BAX in breast cancer brain metastases: a real-time PCR and immunohistochemical evaluation.
Stark AM; Pfannenschmidt S; Tscheslog H; Maass N; Rösel F; Mehdorn HM; Held-Feindt J
Neurol Res; 2006 Dec; 28(8):787-93. PubMed ID: 17288732
[TBL] [Abstract][Full Text] [Related]
57. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
58. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G
Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619
[TBL] [Abstract][Full Text] [Related]
59. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
[TBL] [Abstract][Full Text] [Related]
60. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation.
Ihling C; Szombathy T; Nampoothiri K; Haendeler J; Beyersdorf F; Uhl M; Zeiher AM; Schaefer HE
Heart; 1999 Sep; 82(3):286-93. PubMed ID: 10455077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
